Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
RBC Capital lowered its 12-month price target on Fidelity National Information Services (FIS) to $69 from $86 while retaining an Outperform rating. The adjustment follows FIS’s recent fourth-quarter and full-year 2025 results and the company’s guidance for fiscal 2026. The stock is trading near its 52-week low after a significant six-month decline,…
Raymond James increased its 12-month price target on Bank of Nova Scotia to Cdn$117 from Cdn$114 while retaining an Outperform rating, pointing to greater return-on-equity expansion potential driven by funding and NIM improvements, strategic disposals, fee-based revenue growth and disciplined expense control. The bank's latest quarterly results exc…
Amber B. Wallace, Senior Executive Vice President and Chief Retail & Marketing Officer at Farmers National Banc Corp (FMNB), completed several transactions in company stock in January and February 2026, including small purchases, a substantial block purchase and an intra-day disposition. The company also disclosed shareholder approvals and a pendin…
Bank of America upgraded JM Smucker to Buy and lifted its price target, citing reduced risk from the Hostess Brands acquisition and a pathway to higher earnings, while downgrading General Mills to Neutral as recoveries in pet food and North America Retail lag expectations and weigh on near-term volume and sales.
Investors are watching President Donald Trump’s State of the Union address closely as it arrives amid recent market turbulence and just days after the Supreme Court struck down his emergency-powers tariffs. Market participants warn that discussion of topics from trade policy to Iran or new affordability measures - including proposed 'Trump accounts…
Stifel increased its price objective on DigitalOcean Holdings Inc. (DOCN) to $57 from $48 and kept a Hold rating after the cloud infrastructure provider reported better-than-expected operational results. Management boosted fiscal 2026 revenue growth guidance to 21% and set a 30% target for fiscal 2027, alongside ambitious margin and free cash flow …
SR Bancorp director Thomas Lupo purchased 1,000 shares on February 23, 2026, at $16.47 per share, a transaction valued at $16,465. The purchase increases his direct holdings to 44,015 shares and is concurrent with company dividend and share repurchase activity. External analysis notes both active buybacks and a view that the stock may be overvalued…
Amandine Robin-Caplan, Chief Brand and Communications Officer at Travel & Leisure Co. (NYSE:TNL), sold 3,904 shares of common stock on February 20, 2026, for $74.61 per share, totaling $291,277. After the sale, she directly holds 32,350 shares that had been reported as restricted stock units. The transaction comes as Travel & Leisure reported fourt…
Stifel raised its price objective on Expeditors International of Washington (EXPD) to $141 from $136 while keeping a Hold rating after the logistics company reported fourth-quarter 2025 results that beat expectations on earnings per share. The quarter showed a 3% year-over-year revenue decline driven by ocean rate compression and lower container vo…
A director of PCB Bancorp made a mid-February purchase of company stock worth $112,400, increasing indirect holdings through a family trust. The transactions coincided with a board-approved dividend increase and follow valuation metrics that some analysts deem suggestive of undervaluation and a multi-year pattern of dividend growth.
Truist Securities maintained a Hold rating and a $25.00 price target on Harmony Biosciences Holdings Inc. following the company’s fourth-quarter 2025 earnings call. The bank highlighted legal uncertainty from an ongoing intellectual property trial and the growing prospect of earlier generic competition for Wakix, even as Harmony reported record Wak…
TD Cowen increased its price target for Palvella Therapeutics (PVLA) to $267 from $190 and kept a Buy rating after the company reported positive topline phase 3 results for QTORIN rapamycin in microcystic lymphatic malformation. The trial met its primary endpoint with strong responder rates and statistical significance, prompting multiple firms to …
OGE Energy Corp. director Lyle G. Ganske purchased 10,420 shares of the company's common stock on February 23, 2026, investing $500,067 at an average price of $47.9911 per share. The trade occurred while OGE shares traded close to a 52-week peak and after the company reported fourth-quarter results that exceeded analyst expectations. Third-party an…
Gerald G. Colella, a director at MKS Inc (NASDAQ: MKSI), reported the sale of 20,000 common shares for approximately $5.06 million in two transactions filed on a Form 4 with the SEC. The trades took place on February 20 and February 24, 2026, at weighted average prices of $252.8999 and $253.9675, respectively. The sales occurred while MKSI shares w…
Lucid Capital Markets increased its price target for Palvella Therapeutics (PVLA) to $241 from $212 and kept a Buy rating after the company released Phase 3 SELVA trial data for QTORIN 3.9% rapamycin anhydrous gel. The trial reported a mean mLM-IGA improvement of +2.13 and an 86% responder rate. Management has provided pricing guidance and a commer…
PNC Financial Services Group CEO William S. Demchak sold 50,000 shares on February 20, 2026, for about $11.5 million at a weighted average price of $230.88. The same day included additional internal share movements tied to restricted stock unit vesting and tax-cover sales. PNC reported stronger-than-expected fourth-quarter 2025 core EPS, prompting …
Carnival (CCL) is riding strong booking trends and visible margin improvement driven by debt reduction and lower interest costs. At $31.54 the stock trades at mid-teens P/E with EV/EBITDA below 10 and free cash flow of roughly $2.6B — a setup where operational leverage and cash-flow conversion can drive a 15-25% move higher if bookings and onboard …
The U.S. Securities and Exchange Commission has revised its internal enforcement manual to provide greater uniformity in how it notifies and interacts with subjects of investigations. Key changes include extending the standard response period to four weeks for Wells notices and guaranteeing an opportunity to meet with staff within four weeks of a r…
U.S. authorities announced sanctions on four individuals and three entities for roles in acquiring and distributing cyber tools deemed harmful to U.S. national security. The Department of State also applied intellectual property-related designations under the Protecting American Intellectual Property Act to one person and two entities in connection…
Kingstone Companies (KINS) is a small Northeast P&C insurer trading at a single-digit P/E with 29% reported ROE, low leverage and strong free cash flow. We think the shares can rally to the mid-$20s as underwriting performance stabilizes and the market re-rates a high-ROE, capital-efficient insurer. Trade plan, catalysts and risks below.
Morgan Stanley has moved to a Cautious stance on the U.S. liquefied natural gas sector, citing about 200 million tonnes per annum of new global capacity under construction that is due between 2025 and 2030. The bank expects annual supply additions to peak in 2027-2028 and forecasts weaker Japan Korea Marker (JKM) prices, a combination it says will …
Ten years after the inaugural liquefied natural gas shipment departed from Louisiana, the United States has become the world’s largest supplier of LNG. Supported by plentiful domestic gas, competitive feedgas costs and flexible contracts, U.S. exporters are accelerating capacity additions that industry participants say could roughly double output o…
Peter Mandelson, 72, was released from police custody on Tuesday after being arrested in London on suspicion of misconduct in public office. His lawyers say the detention followed an unfounded claim that he intended to relocate permanently overseas. The arrest occurs amid a criminal probe that began after the government passed correspondence betwee…
Wedbush reaffirmed an Outperform rating and a $340 price target on IBM after the stock plunged following an Anthropic announcement about COBOL modernization. Analysts note IBM’s entrenched mainframe presence, strategic AI partnerships, and services that support migration and compliance. Other firms including Evercore ISI and Jefferies have also rei…
Leerink Partners reaffirmed an Outperform rating and a $24.00 price target for Fulcrum Therapeutics after the release of full Phase 1b PIONEER results for pociredir in sickle cell disease. The firm continues to view the drug positively and estimates a material lead over competitors, while broader market reactions and other broker opinions remain mi…
